Hepatitis C y B en pacientes con insuficiencia renal crónica y trasplante renal. Historia natural y decisiones terapéuticas
Resumen
Texto completo:
PDFReferencias
Pereira B, Levey A. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997;51:981-99.
Garassini SM, Garassini Ch M. Hepatitis C. ¿Cómo se transmite? ¿Se puede prevenir? Gen 2000;54:116-35.
Schneeberger PM, Keur I, Van-der Vliet W, Van-Hoek K, Boswijk H, Van-Loon AM, Van-Dijk WC, et al. Hepatitis C virus infection in diálisis centres in The Netherlands: a nacional survey by serological and molecular methods. J Clin Microbiol 1998;36:1711- 1715.
Fabrizi F, Poordad F, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002;36:3-10.
Martin P, Friedman LS. Chrinic viral hepatitis and the management of chronic renal failure. Kidney Int 1995;47:1231-1241.
Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Vinson S, et al. Acquisition of Hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay . Am J Kidney Dis 1998;31:647-654.
Mathurin P, Mouquet C, Poynard T, Sylla Ch, Benalia H, Fretz C, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999;29:257-63.
Djordjevic V, Stojanovic K, Stojanovic M, Stefanovic V. Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study. Int J Artif Organs 2000;23: 181-188.
Nakayama E, Akiba T, Marumo F, Sato C. Prognosis of antihepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000;11:1896-1902.
Zuramay C, Páez R, León R, Ruiz ME, Infante M. Evaluación histological de infección por hepatitis C en pacientes en hemodiálisis. Gastroent y Hepatol 2002;25 suppl 2:13.
Vosnides GG. Hepatitis C in renal transplantation. Kidney Int. 1997;52:843-861.
Macellin P, Boyer N, Behamoud Jp, Erlingy S. Interferon alfa therapy for chronic hepatitis C in special patient populations. Dig Dis Sci 1996;41:126S-130S.
Bruchfeld A, Stahle L, Anderson J, Schvarea R. Ribavirin treatment in dialysis patients with chronic hepatitis C infection a pilot study. J Viral Hep 2001;8:287-92.
Pereira B, Natov S, Bouthot B, et al. Rffect of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 1998;53:1374-81.
Pol S, Thiers V, Carnot F, et al. Efficacy and tolerance of alfa 2 b interferon therapy on HCV infection of hemodialized patients. Kidney Int 1995;47:1412-8.
Rao KV, Anderson RW, Kasiske BL, Dahe RC. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993;94:241-250.
Lamb M, Marks I, Wynohradnyk L. 40 KDa peginterferon alfa 2 a (Pegasys) can administered safely inpatients with end stage renal disease. Hepatology 2001;34:826 A.
Chen–Hua Liu and Jia-Horng Kao. Treatment of hepatitis C virus infection in patients with end-stage renal disease. Journal of Gastroenterology and Hepatology 2010; 1440-1746.
Fabrizi F, Messa P, Martin P. Transmission of hepatitis C virus infection in hemodialysis: current concepts. Int J Artif Organs 2008;31:1004-16.
Fabrizi F, Takkouche B , Lunghi G , Dixit V , Messa P, Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat. 2007;14:697-703.
Zucker K, Cirocco R, Roth D, Olson H, Burke GU, Nery J, Esquenazi V, et al. Depletion of hepatitis C virus from procured kidneys using pulsatile perfusion preservation. Transplantation 1994;57:832-840.
Pawa S, Mutchnick M, Ehrinfreis M, et al. Patients with chronic hepatitis C and chronic renal insufficiency or end stage renal. Disease respond poorly to interferon monotherapy. Hepatology 2004;40 (Suppl 1):332 A.
Russo M, Ghalib R, Sigal S, et al. A multicentre randomized trial of pegylated interferon alfa 2b monotherapy (peg-intron) en patients with chronic hepatitis C and stage kidney disease on dialysis. Hepatology 2004;40(Suppl 1):339 A.
Nutt A, Hassan H, Lindsey J, Lamps L, Raufman J. Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near-normal serum alanine aminotransferase levels. Am J Med 2000;109: 62-4.
Koff J, Younossi Z. Hepatitis C with normal liver enzymes: to treat or not to treat. Pro: Most patients should be treated. Am J Gastroenterol 2004;99:972-3.
Reddy KR. Hepatitis C with normal liver enzymes: to treat or not to treat. Con: most patients should not be treated. Am J Gastroenterol 2004;99:973-5.
Jacobson I, Russo M, Lebovics E, et al. Interferon alfa-2b and ribavirin for patients with chronic hepatitis C and normal ALT: final results. Gastroenterology 2002;36:A-627.
Zeusem S, Diago M, Gane E, et al. Fort he PEGASYS Study NR16071 Investigator Group. Peginterferon alfa-2 a (40 xxxxx=) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. Gastroenterology 2004;127:1724-32.
The NIH Consensus Development Conference Statement: Management of Hepatitis C. Hepatology 1997;26(Suppl 1):2S- 10S.
The NIH Consensus Development Conference Statement: Management of Hepatitis C. Hepatology 2002;36(Suppl 5):3S- 20S.
Ping-Nam Wong, Tang–Tat Fung, et al. Hepatitis B virus infection in dialysis patients. Journal of Gastroenterology and Hepatology 2005;20:1641-1651.
Perrillo Robert. Hepatitis B and renal transplation: Securing the Sword of Damocles. Hepatology;36(5):1042-1045.
Fabrizi F, Lunghi G, Martin P. Hepatitis B virus infection in hemodialysis: recent discoveries. J Nephrol 2002;15:463-8.
Campistol JM, Esforzado N, Martinez J, et al. Efficacy and tolerance of interferon-alpha (2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment. Nephrol. Dial. Transplant. 1999;14: 2704-9.
Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P. Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials. Transplantation 2004;77:859-64.
Lok AS, McMahon BJ, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology 2004;39: 857-61.
DOI: http://dx.doi.org/10.61155/gen.v66i1.188
VIDEOS GEN
Autor: Dr. Freddy Pereira Graterol
 |  |  |
CPRE. Sitio de sección del ducto pancreático principal | Drenaje transgástrico de pseudoquiste pancreático | CPRE. Sección del ducto hepático izquierdo por traumatismo de abdomen |
Autora: Dra. Anais Karina García Yaraure
 |  | |
Cavernomatosis portal Pre Colocacion de TIPS. | Cavernomatosis portal Post Colocacion de TIPS. |
 |  |  |
Revista GEN
ISSN: 0016-3503 e-ISSN: 2477-975X